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of the results
Introduction
Conducting a research project is one of the ﬁrst key
steps in a young person’s gastrointestinal (GI) career.
The success of the project will impact on her or his
interest in research and motivation them to embrace
an academic career. An appropriate methodology
includes a statistical analysis plan, which is often seen
as the most complex part of the process, which requires
eﬃcient data collection and active collaboration with
the methodologist–statistician. Several tips can ease
this process and increase the productivity of the trai-
nee’s work. Here, we will discuss some general guide-
lines that will help to plan the statistical analysis. We
will frequently use colonoscopy screening as an illustra-
tive example.
Analysis plan
From a hunch to a research hypothesis and a
clear main objective
A project typically starts with an observation, a ques-
tion or a hunch. The ﬁrst challenge is to transform such
a vague idea into a clear main objective. As a start, it is
worth explaining the question in plain, non-medical
language to a colleague. A good hunch can be
expressed as a hypothesis, which can be conﬁrmed or
refuted. Major inconsistencies frequently surface at this
point. Science should be viewed as a conversation
where an idea, with its reasoning and calculated uncer-
tainty, will be communicated to other scientists.
One should gradually progress from a vague idea to
a speciﬁc main objective expressed in medical language
using deﬁned terms (i.e. ‘assess the decrease in colorec-
tal cancer (CRC) mortality after a single screening col-
onoscopy at 50 years compared to no screening’).
Analysis plan content
The analysis plan should be ﬁxed before starting
data collection. Investing intellectual eﬀort at the begin-
ning will save time during data collection and later. In
addition, a pre-speciﬁed analysis plan greatly increases
the credibility of study results, guarding against data
dredging. A study protocol and analysis plan can be
registered at various places (e.g. clinicaltrials.gov for
randomized controlled trials and observational studies,
or PROSPERO for systematic reviews and meta-
analyses), and is required for work to be published in
several journals.
A ﬁrst step of an analysis plan is the deﬁnition of the
study population that it most appropriate to assess the
main objective. Inclusion criteria (e.g. ‘age 50 years’)
and exclusion criteria (i.e. ‘history of CRC’) should
unambiguously characterize the study population. Keep
in mind that your ﬁndings will be only generalizable to a
population with similar inclusion and exclusion criteria.
Inclusion periods and follow-up should be clearly stated.
The term outcome refers to the measured variable
(e.g. ‘CRC mortality’), whereas the endpoint refers to
its quantitative expression (for instance ‘CRC-speciﬁc
mortality within 5 years after colonoscopy screening’).
For some speciﬁc questions, you can use composite
endpoints (a combination of individual endpoints),
which will have methodological implications that are
outside the scope of this manuscript. All other items
collected, including treatment/exposure (e.g. ‘colonos-
copy’) and covariates, should be deﬁned, with all pos-
sible values stated.
The study design (i.e. randomized, interventional vs.
observational and/or prospective vs. retrospective),
should be clearly deﬁned, but a detailed discussion is
outside the scope of this manuscript. In observational
studies (notably retrospective), which will be the vast
majority of projects for a young trainee, handling miss-
ing data should be pre-planned. The absence of ran-
domization also requires the investigator to control
for confounding. Confounders are parameters asso-
ciated with both treatment/exposure and the outcome,
and only randomization can reasonably ensure an
equal distribution of confounders over the study popu-
lation. For instance, parameters associated with health-
seeking behaviour (i.e. ‘participation in colonoscopy
screening’) are also associated with a healthier lifestyle
(e.g. ‘no smoking’, ‘healthier diet’ and ‘lower body
weight’). Several methods have been applied to control
for confounding. Conventional methods include strati-
ﬁcation, matching and multivariate regression, while
newer techniques include propensity scoring and mar-
ginal structural models.
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The choice of the test is determined by the structure
of the endpoint variable (quantitative vs. qualitative),
whether observations are paired or unpaired, and how
the variables are distributed. For a survival analysis,
speciﬁc statistical tools (notably Kaplan–Meier and
Cox analyses) are available. Hypothesis and statistical
signiﬁcance testing according to the p-value is based on
proof by contradiction. The p-value is calculated under
the assumption of the absence of an eﬀect: the null
hypothesis (i.e. ‘no diﬀerence among patients with or
without colonoscopy screening’). The p-value is the
probability of measuring an eﬀect at least as strong as
what was observed, given that there is no true diﬀerence
between groups. The null hypothesis is typically
rejected if the p-value falls below an arbitrary value of
p< 0.05. However, this is no proof that the study
hypothesis is true. Vice versa, a p-value> 0.05 is no
proof of the absence of an eﬀect. Smaller p-values
alone do not guarantee an appropriate methodology.
In the discussion of the clinical relevance of the results,
magnitudes of eﬀects (i.e. ‘1 vs. 20% CRC mortality
reduction’) and the implications for the patient should
be considered.
Subgroup and sensitivity analyses should be pre-
planned to assess the robustness of the results accord-
ing to changes in all aspects of study methodology.
For instance, when testing in deﬁned patient subgroups
(e.g. ‘women’ and ‘> 80 years’) with a diﬀerent deﬁn-
ition of the outcome variable (‘mortality reduction
within 2 vs. 5 years’), a diﬀerent statistical test or an
alternative approach towards missing data can be per-
formed. No strict rules apply and common sense should
be employed. Consistent results in a limited number of
pre-deﬁned sensitivity analyses increase conﬁdence
towards the results of a study.
A power analysis is recommended to estimate the
number of patients necessary to answer the primary
research question. The results of the power analysis indi-
cate how many patients should be included to detect a
statistically signiﬁcant diﬀerence (e.g. p< 0.05) with a
given statistical power, for instance 80 or 90%. Power
refers to the probability of detecting an eﬀect when it is
present. For a meaningful study, the size of this eﬀect
should also be of practical signiﬁcance.
Data collection
Data collection is mostly performed by the trainee, fre-
quently in retrospective studies including a review of
medical records. It should only start after the ﬁnaliza-
tion of the analysis plan, in order to avoid multiple data
collection rounds. The analysis plan should include
comprehensive deﬁnitions and descriptions (qualitative
or quantitative) of all collected variables. When data
are summarized there is a risk of losing information;
thus, collection of raw data with summarizing in the
analysis phase is preferable.
Datasets should be de-identiﬁed, in order to protect
individual privacy. It is recommended that a unique
anonymous identiﬁer is created as a study number for
each patient, and that these identiﬁers are used
throughout all datasets.
Data management, i.e. formatting the data to ﬁt the
requirements of the statistical analysis, can be time-
consuming. Thus, data should be collected in a that
manner minimizes data management. First, coded
data are easier to analyze than free text. Second, vari-
able names should respect the general naming conven-
tions of the most used statistical software programmes.
A commonly valid name starts with a letter and consists
of a maximum of 32 characters including letters, num-
bers and the underscore character.
We recommend data collection using a Clinical Data
Management System (CDMS), which is nowadays
based on electronic data capturing (EDC) systems.
An EDC system should also be used in retrospective
observational studies, even those with a small sample
size, since it has several advantages compared to
spreadsheets. EDC systems allow restricted access in
case of multiple users, while spreadsheets have very
limited permission controls. Constraints for data
entry are also available in EDC systems, which will
immediately identify data errors or omitted data.
Conversely, the use of spreadsheets may require a
lengthy process of checking for errors and consolidat-
ing data. The use of Excel or similar spreadsheet soft-
ware, even though widely available, is discouraged for
data entry since such software does not meet most of
the criteria mentioned above. The choice of the EDC
software solution depends on the local institution; con-
tact the local information technology staﬀ to ﬁnd out
the current license software agreements. Research
Electronic Data Capture (REDCap) is a web-based
EDC software solution developed by Vanderbilt
University, which is widely used in the academic
research community (https://www.project-redcap.org).
Collaboration with the
methodologist–statistician
Unless your mentor has advanced skills in methodology
and statistics, you need to collaborate with a method-
ologist and a statistician. The methodologist will help
the clinician to design the study, while the statistician
will perform the statistical analysis and produce data
analysis reports. In practice, it is mostly the same indi-
vidual, who may already have some clinical knowledge
in the topic of interest after previous collaborations
with your research group. Such collaboration is facili-
tated if the clinician’s skills in methodology and
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statistics, and the statistician’s clinical knowledge, is
high. Involving the statistician–methodologist in the
study design process can enhance the quality of the
study. Furthermore, the statistician–methodologist
can help design the database and improve data collec-
tion. However, the clinician researcher should still
maintain the initiative and lead the project in accord-
ance with two points: answering the research question
and providing clinical relevance.
Conclusion
Planning statistical analysis based on a research
hypothesis can be a diﬃcult task for an unexperienced
trainee. All research projects should start with a clear
main objective, from which the analysis plan will be
developed. A research project can fail if data are
poorly collected. All of the tips provided here will
help the researcher clinician to have a fruitful collabor-
ation with the methodologist–statistician. Remember
that the ﬁrst research project is always the most diﬃcult
one and that you will gain experience over the years.
The journey is worth it!
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